BNB Plus Corp. (BNBX)
NASDAQ: BNBX · Real-Time Price · USD
3.000
-0.100 (-3.23%)
At close: Dec 5, 2025, 4:00 PM EST
3.060
+0.060 (2.00%)
After-hours: Dec 5, 2025, 7:58 PM EST
BNB Plus Employees
As of September 30, 2024, BNB Plus had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$77,980
Profits / Employee
$847,396
Market Cap
3.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BNBX News
- 18 days ago - Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board - Business Wire
- 5 weeks ago - BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update - Business Wire
- 6 weeks ago - Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million - Business Wire
- 2 months ago - Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy - Business Wire
- 2 months ago - Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation - Business Wire
- 2 months ago - Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - Accesswire
- 4 months ago - Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - Accesswire
- 4 months ago - Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Accesswire